Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)

Insight Molecular Diagnostics has reported Return on Invested Capital for 3 years, with the latest figure at 0.07% in Q3 2024.

• Quarterly Return on Invested Capital changed N/A year-over-year to 0.07% in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.07% (changed N/A YoY) and the FY2022 annual result came in at 0.22%, up 1.0% from the prior year.
• Return on Invested Capital improved to 0.07% in Q3 2024 per IMDX's latest filing, from 0.09% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.02% in Q3 2021 and troughed at 0.11% in Q1 2024.
• A 3-year average of 0.05% and a median of 0.04% in 2021 frame the typical range for Return on Invested Capital.
• The widest YoY moves for Return on Invested Capital: up 1 bps in 2021, down 1 bps in 2021.
• Over 3 years, Return on Invested Capital stood at 0.05% in 2020, then grew by 24 bps to 0.04% in 2021, then sank by 109 bps to 0.07% in 2024.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.07%, 0.09%, and 0.11% for Q3 2024, Q2 2024, and Q1 2024 respectively.